As of 2024-12-15, the Intrinsic Value of Antibe Therapeutics Inc (ATE.TO) is
-1.77 CAD. This ATE.TO valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.30 CAD, the upside of Antibe Therapeutics Inc is
-701.01%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-1.77 CAD
Intrinsic Value
ATE.TO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-1.77 - -1.77 |
-1.77 |
-701.01% |
| P/E |
0.28 - 0.28 |
0.28 |
-3.8% |
| DDM - Stable |
(2.25) - (7.31) |
(4.78) |
-1720.4% |
| DDM - Multi |
(0.07) - (0.18) |
(0.10) |
-134.3% |
ATE.TO Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
15.53 |
| Beta |
-0.16 |
| Outstanding shares (mil) |
52.65 |
| Enterprise Value (mil) |
11.43 |
| Market risk premium |
5.10% |
| Cost of Equity |
11.70% |
| Cost of Debt |
5.00% |
| WACC |
7.70% |